MHRA
Buyer information published with procurement notices.
- Published identifier
- GB-PPON PJLJ-9824-VXPG
- Address
- London, UKI42, E14 4PU, United Kingdom
- First notice
- 14 Feb 2025
- Latest notice
- 16 Oct 2026
Published procurement activity · 79 tenders
Buyer information published with procurement notices.
Open the opportunity to review the published procurement information.
Purchase and maintenance of a Multiplex Analyser for Pneumococcal vaccines
Economic impact assessment of the potential medicine reclassification in the UK
consultancy to carry out research, interviews and intelligence gathering, data analyses and make recommendations for the upcoming MHRA strategy. This work is needed to best understand the landscape of the life sciences sector and understanding capabilities, perspectives and areas of predicted growth and interest across countries
MHRA – Scottish Collaboration Proposal to Pilot Next-Generation Medication Surveillance and Pharmacovigilance to the Medicines and Healthcare products Regulatory Agency
The MHRA is looking to procure a bespoke, custom-built negative pressure, Flexible Film Isolator (FFI) linked via a ventilated transfer junction to an existing class III MSC in our SAPO4 containment facility. The FFI shall run at negative pressure. The design must fit the space in the laboratory to enable ergonomic use. The FFI
The MHRA has a requirement to award a contract for the Purchase and maintenance of an Advanced Electroporation system.
The Agency is looking for a partner who can provide a holistic strategy covering all the different types of data and applications in use across the MHRA. The Agency has data that must be highly available and easy to restore quickly, and data that is very unlikely to be needed regularly but must be retained as a historical record
The very important time constrains (before 20th of March 2026) attached to the awarded grant finance, for our specific objective, This supplier expertise with expressing our nanobody sequences in different formats, their speed, competitive pricing and MHRA’s prior in house validation of nanobody products made by this supplier ,
one expert accredited medical assessor focusing on reviewing the proposals shared by two pharmaceutical companies, preparing for, participating in and documenting workshops, and other meetings, undertaking the writing of the scientific manuscript, guidance and other publications. This external support will allow for pioneer work
Organisation details and tender classifications reflect information published by the original procurement sources. Similar buyer names are grouped only where an official identifier or compatible name and postcode provide a safe link.